about
Co-administration of IL-1+IL-6+TNF-α with Mycobacterium tuberculosis infected macrophages vaccine induces better protective T cell memory than BCGDevelopment of a guinea pig immune response-related microarray and its use to define the host response following Mycobacterium bovis BCG vaccinationAnimals devoid of pulmonary system as infection models in the study of lung bacterial pathogensDevelopment of new vaccines and drugs for TB: limitations and potential strategic errorsLocation of persisting mycobacteria in a Guinea pig model of tuberculosis revealed by r207910.Tuberculosis: from genome to vaccine.Drug-resistant tuberculosis: controversies and challenges in pediatrics.Protective efficacy of a recombinant BCG secreting antigen 85B/Rv3425 fusion protein against Mycobacterium tuberculosis infection in mice.Disseminated disease severity as a measure of virulence of Mycobacterium tuberculosis in the guinea pig model.A multistage mycobacterium tuberculosis subunit vaccine LT70 including latency antigen Rv2626c induces long-term protection against tuberculosis.Recombinant Mycobacterium bovis BCG prime-recombinant adenovirus boost vaccination in rhesus monkeys elicits robust polyfunctional simian immunodeficiency virus-specific T-cell responses.The guinea pig as a model of infectious diseases.Evaluation of the eukaryotic expression of mtb32C-hbha fusion gene of Mycobacterium tuberculosis in Hepatocarcinoma cell line.Synthesis and structural insight into ESX-1 Substrate Protein C, an immunodominant Mycobacterium tuberculosis-secreted antigen.Construction of a DNA Vaccine Encoding Mtb32C and HBHA Genes of Mycobacterium tuberculosisLive tuberculosis vaccines based onphoPmutants: a step towards clinical trials
P2860
Q27437712-3BA1F14B-932A-4F59-9A7E-79BCDCFBB93CQ30231394-988396DF-62A0-4527-B073-0C4F01B4DAA7Q35048029-F7402807-BAED-4D0D-A655-60C41EA33B9FQ35065531-06E561FF-EB75-486B-8CA3-93403859BC55Q36094916-B5400AA8-0A0A-41B5-A092-8925E1C92D29Q36238724-9BA08ED8-370A-4533-A955-5F41E946C024Q36322140-1722A8EB-8DF9-4D33-BF6C-B1824B8EE38FQ36849823-0591F96F-4FCF-4905-A5A7-F163FA5CE311Q36948262-F54CD124-5C54-4959-9609-2BAE2361E568Q37135418-3EC51AE9-5A56-40CD-99D0-8F299C2EB91BQ37191912-5C23B6E5-ADC1-4666-9B41-6778D2C01493Q37251175-49CDF016-D504-44B3-8881-1A55FAB60CC3Q38764202-ADBBA2C3-A819-438F-914D-0D42D2B4A852Q39901819-B1B7B4B7-F0E6-4B28-9D19-B9E847ACBEADQ41224466-18E514A5-C3D7-41EE-9366-695C5A827DCCQ58834940-94B615E0-A859-4005-8FE9-BD3D04B328AA
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Current progress in tuberculosis vaccine development.
@ast
Current progress in tuberculosis vaccine development.
@en
type
label
Current progress in tuberculosis vaccine development.
@ast
Current progress in tuberculosis vaccine development.
@en
prefLabel
Current progress in tuberculosis vaccine development.
@ast
Current progress in tuberculosis vaccine development.
@en
P1433
P1476
Current progress in tuberculosis vaccine development.
@en
P2093
Ian M Orme
P304
P356
10.1016/J.VACCINE.2005.01.062
P407
P577
2005-03-01T00:00:00Z